Abstract
Management of acute episode is the goal treatment in patients with sustained tachycardia. Long-term objetive is to prevent and/or control new arrhythmic episodes and avoiding sudden death in malignant ventricular arrhythmias. Patient's pattern of presentation and hemodynamic tolerance provide knowledge for the initial management. According to these data, decisions will be made to reverse the arrhythmia by external cardioversion or antiarrhythmic drugs. Once the acute phase has been solved, the arrhythmia should be evaluated to prevent further episodes. Long-term tachycardia management options have evolved considerably in recent decades, and catheter ablation has substitued antirrhytmic drugs as definitive treatment. On the other hand, implantable cardioverter-defibrillators (ICDs) are standard therapy in patients with a risk of sudden death due to a malignant ventricular arrhythmias.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have